Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications / Interações medicamentosas em terapia intensiva materna: prevalência, fatores e medicamentos de risco

ABSTRACT Objective: To characterize severe potential drug interactions in maternal intensive care, and to determine their frequency, risk factors and potential risk medications. Methods: An observational and longitudinal study conducted between December 2014 and December 2015 in a maternal intensive care unit. Clinical data were collected and severe potential drug interactions were identified on pregnant inpatients. The drug interactions were classified by type, prevalence and exposure rate. A multivariate logistic regression model was used to identify the severe potential drug interactions and the related drugs (p<0.05). Results: A total of 95.1% of patients were exposed to, at least, one potential drug interaction; in that, 91.7% 33.9% were related to, respectively, moderate and severe potential drug interactions. The patients were exposed, on average, on 69.2% of days they were in the intensive care unit. The main drugs involved in more severe drug interactions were magnesium sulfate, metoclopramide, propranolol and diazepam. Conclusion: The severe potential drug interactions were observed in almost all patients of the study, and, approximately one third of those interactions were related to greater severity and resulted in exposure during long hospital stay. The higher number of prescribed drugs and its previous use of medications at home increase the occurrence of severe potential drug interactions.

RESUMO Objetivo: Caracterizar as interações medicamentosas potenciais graves em terapia intensiva materna, e determinar sua frequência, os fatores e os medicamentos de risco associados à ocorrência dessas interações. Métodos: Estudo observacional e longitudinal executado entre dezembro de 2014 a dezembro de 2015, conduzido em uma unidade de terapia intensiva materna. Foram coletados dados clínicos e identificadas interações medicamentosas potenciais graves de gestantes admitidas. As interações medicamentosas foram caracterizadas quanto ao tipo, à prevalência e à taxa de exposição. Um modelo multivariado de regressão logística foi utilizado para identificação de fatores associados à ocorrência de interações medicamentosas potenciais graves e os medicamentos implicados (p<0,05). Resultados: Um total de 95,1% das pacientes foi exposto a, no mínimo, uma interação medicamentosa potencial, com 91,7% delas envolvidas com interações medicamentosas potenciais moderadas e 33,9% com as interações graves. As pacientes ficaram expostas, em média, em 69,2% dos dias que estiveram sob terapia intensiva. Os principais medicamentos implicados em interações medicamentosas de maior gravidade foram sulfato de magnésio, metoclopramida, propranolol e diazepam. Conclusão: As interações medicamentosas potenciais graves ocorreram na maioria das pacientes avaliadas. Aproximadamente um terço das interações foram graves e levaram à maior exposição por um longo período de internação. Maior número de fármacos prescritos e uso prévio domiciliar de medicamentos elevam a ocorrência de interações medicamentosas potenciais graves.

Effects of lidocaine and magnesium sulfate in attenuating hemodynamic response to tracheal intubation: single-center, prospective, double-blind, randomized study / Os efeitos da lidocaína e do sulfato de magnésio na atenuação da resposta hemodinâmica à intubação orotraqueal: estudo unicêntrico, prospectivo, duplamente encoberto e aleatorizado

Abstract Background and objectives: Hemodynamic response to airway stimuli is a common phenomenon and its management is important to reduce the systemic repercussions. The objective of this study is to compare the efficacy of intravenous magnesium sulfate versus lidocaine on this reflex hemodynamics after laryngoscopy and tracheal intubation. Methods: This single-center, prospective, double-blind, randomized study evaluated 56 patients ASA 1 or 2, aged 18-65 years, scheduled for elective surgeries under general anesthesia with intubation. The patients were allocated into two groups: Group F received 30 mg·kg-1 of magnesium sulphate and Group L, 2 mg·kg-1 of lidocaine, continuous infusion, immediately before the anesthetic induction. Blood pressure (BP), heart rate (HR), and bispectral index (BIS) were measured in both groups at six different times related to administration of the study drugs. Results: In both groups there was an increase in HR and BP after laryngoscopy and intubation, compared to baseline. Group M showed statistically significant increase in the values of systolic and diastolic blood pressure after intubation, which was clinically unimportant. There was no difference in the BIS values between groups. Among patients receiving magnesium sulfate, three (12%) had high blood pressure versus only one among those receiving lidocaine (4%), with no statistical difference. Conclusion: Magnesium sulfate and lidocaine have good efficacy and safety for hemodynamic management in laryngoscopy and intubation.

Resumo Justificativa e objetivos: A resposta hemodinâmica aos estímulos das vias aéreas é um fenômeno comum e seu controle é importante para diminuir as repercussões sistêmicas. O objetivo deste trabalho é comparar os efeitos da administração endovenosa de sulfato de magnésio versus lidocaína na hemodinâmica desse reflexo após a laringoscopia e intubação orotraqueal. Métodos: Este estudo duplamente encoberto, aleatorizado, unicêntrico e prospectivo avaliou 56 pacientes, ASA 1 ou 2, entre 18 e 65 anos, escalados para cirurgias eletivas sob anestesia geral com intubação orotraqueal. Foram alocados em dois grupos, o M recebeu 30 mg·kg-1 de sulfato de magnésio e o L, 2 mg·kg-1 de lidocaína, em infusão contínua, imediatamente antes da indução anestésica. Os valores de pressão arterial (PA), frequência cardíaca (FC) e índice biespectral (BIS) foram aferidos nos dois grupos em seis momentos relacionados com a administração dos fármacos do estudo. Resultados: Em ambos os grupos houve aumento na FC e PA após a laringoscopia e intubação, em relação aos valores basais. No Grupo M observou-se elevação estatisticamente significativa, mas clinicamente pouco importante, nos valores das pressões arteriais sistólica e diastólica após a intubação. Não houve diferença nos valores de BIS entre os grupos. Dos pacientes que receberam o sulfato de magnésio, 3 (12%) apresentaram episódio de hipertensão, ao passo que apenas um dos que receberam lidocaína (4%) apresentou esse sinal, sem diferença estatística. Conclusão: Sulfato de magnésio e a lidocaína apresentam boa eficácia e segurança no controle hemodinâmico à laringoscopia e intubação.

Comparison between magnesium sulfate and dexmedetomidine in controlled hypotension during functional endoscopic sinus surgery / Comparação entre dexmedetomidina e sulfato de magnésio em hipotensão controlada durante cirurgia funcional endoscópica dos seios paranasais / Comparación entre el sulfato de magnesio y la dexmedetomidina en hipotensión controlada durante cirugía funcional endoscópica de los senos paranasales

BACKGROUND AND OBJECTIVES: It is crucial to decrease bleeding during functional endoscopic sinus surgery. Our primary goal was to investigate the effects of magnesium sulfate and dexmedetomidine used for controlled hypotension on the visibility of the surgical site. METHODS: 60 patients aged between 18 and 65 years were enrolled. In the magnesium sulfate group (Group M), patients were administered 40 mg/kg magnesium sulfate in 100 mL saline solution over 10 min as the intravenous loading dose 10 min before induction, with a subsequent 10-15 µg/kg/h infusion during surgery. In the dexmedetomidine group (Group D), patients were administered 1 µg/kg dexmedetomidine in 100 mL saline solution as the loading dose 10 min before surgery and 0.5-1 µg/kg/h dexmedetomidine during surgery. Deliberate hypotension was defined as a mean arterial pressure of 60-70 mmHg. RESULTS: Bleeding score was significantly decreased in Group D (p = 0.002). Mean arterial pressure values were significantly decreased in Group D compared to that in Group M, except for the initial stage, after induction and 5 min after intubation (p < 0.05). The number of patients who required nitroglycerine was significantly lower in Group D (p = 0.01) and surgeon satisfaction was significantly increased in the same group (p = 0.001). Aldrete recovery score ≥9 duration was significantly shorter in Group D (p = 0.001). There was no difference between the two groups in terms of recovery room verbal numerical rating scale. CONCLUSIONS: Dexmedetomidine can provide more effective controlled hypotension and thus contribute to improved visibility of the surgical site. .

JUSTIFICATIVA E OBJETIVOS: Diminuir o sangramento durante a cirurgia funcional endoscópica dos seios paranasais é essencial. Nosso objetivo primário foi investigar os efeitos de dexmedetomidina e sulfato de magnésio, usados para o controle da hipotensão, sobre a visibilidade do sítio cirúrgico. MÉTODOS: Foram incluídos no estudo 60 pacientes entre 18 e 65 anos. No grupo sulfato de magnésio (Grupo M), receberam 40 mg de sulfato de magnésio em 100 mL kg-1 de solução salina durante 10 minutos como dose de carga intravenosa 10 minutos antes da indução e infusão subsequente de 10-15 µg kg-1 h-1 durante a cirurgia. No grupo dexmedetomidina (Grupo D), receberam 1 µg kg-1 de dexmedetomidina em 100 mL de solução salina durante 10 minutos como dose de carga 10 minutos antes da cirurgia e 0,5-1 µg kg-1 h-1 de dexmedetomidina durante a cirurgia. Hipotensão controlada foi definida como pressão arterial média de 60-70 mmHg. RESULTADOS: O volume de sangramento diminuiu significativamente no grupo D (p = 0,002). Os valores da pressão arterial média foram significativamente menores no Grupo D, em comparação com o Grupo M, exceto no estágio inicial, pós-indução e cinco minutos pós-intubação (p < 0,05). No Grupo D, o número de pacientes que necessitou de nitroglicerina foi significativamente menor (p = 0,01) e o grau de satisfação do cirurgião foi significativamente maior (p = 0,001). O tempo de recuperação para atingir o escore de Aldrete ≥ 9 foi significativamente menor no grupo D (p = 0,001). Não houve diferença entre os dois grupos em relação aos escores da escala numérica de classificação verbal na sala de recuperação. CONCLUSÕES: Dexmedetomidina pode proporcionar um controle mais eficaz da hipotensão e contribuir, assim, para uma melhor visibilidade do sítio cirúrgico. .

JUSTIFICACIÓN Y OBJETIVOS: Disminuir el sangrado durante la cirugía funcional endoscópica de los senos paranasales es esencial. Nuestro objetivo primario fue investigar los efectos de la dexmedetomidina y del sulfato de magnesio, usados para el control de la hipotensión, sobre la visibilidad del campo quirúrgico. MÉTODOS: Fueron incluidos en el estudio 60 pacientes entre 18 y 65 años. En el grupo sulfato de magnesio (grupo M), recibieron 40 mg de sulfato de magnesio en 100 mL/kg-1 de solución salina durante 10 min como dosis de carga intravenosa 10 min antes de la inducción e infusión subsecuente de 10-15 µg/kg-1/h-1 durante la cirugía. En el grupo dexmedetomidina (grupo D), recibieron 1 µg/kg-1 de dexmedetomidina en 100 mL de solución salina durante 10 min como dosis de carga 10 min antes de la cirugía y 0,5-1 µg/kg-1/h-1 de dexmedetomidina durante la cirugía. La hipotensión controlada se definió como presión arterial media de 60-70 mmHg. RESULTADOS: El volumen de sangrado disminuyó significativamente en el grupo D (p = 0,002). Los valores de la presión arterial media fueron significativamente menores en el grupo D en comparación con el grupo M, excepto en el estadio inicial, postinducción y 5 min postintubación (p < 0,05). En el grupo D, el número de pacientes que necesitó nitroglicerina fue significativamente menor (p = 0,01) y el grado de satisfacción del cirujano fue significativamente mayor (p = 0,001). El tiempo de recuperación para alcanzar la puntuación de Aldrete ≥ 9 fue significativamente menor en el grupo D (p = 0,001). No hubo diferencia entre los 2 grupos con relación a las puntuaciones de la escala numérica de clasificación verbal en la sala de recuperación. CONCLUSIONES: La dexmedetomidina puede proporcionar un control más eficaz de la hipotensión y contribuir así a una mejor visibilidad del campo quirúrgico. .

Comparison of efficacy and safety of magnesium sulphate in 12 hours versus 24 hours after last fit in eclamptic patients

To compare the efficacy and safety of magnesium sulphate in 12 hours regime versus 24 hours regime after last fit in eclamptic patients. Randomized controlled trial study. This randomized controlled trial was carried out at Department of Obstetrics and Gynaecology, Unit-Ill, Nishtar Medical College/Hospital Multan from 01.06.2013 to 31.05.2014. Total 120 patients with eclampsia were included. All patients were given 4g of magnesium sulphate [20% solution] intravenously slowly [15 mins] as loading dose. After receiving the loading dose randomization was performed by block design. So 60 patients for 12 hour regime while 60 patients for 24 hour regime [control group]. In 12 hour regime group magnesium sulphate maintenance dose of Ig [20% solution] was given 1 hourly intravenously for 12 hours after last fit. In 24 hour regime group magnesium sulphate maintenance dose of ig [20% solution] was given 1 hourly intravenously for 24 hours after last fit. Efficacy in shape of recurrence of fits, number of fits and safety in shape of pulmonary oedema, oliguria and loss of knee jerk reflex,Nausea and flushing was noted. Total 120 patients were studied falling in age group of 20 to 40 years. Eclampsia was most commonly occurring in young and primigravida patients. Majority of eclamptic patient had diastolic B.P 110 or > 1 l0mmHg. None of patients in either group had eclamptic fit. Loss of knee jerk reflex seen in 5 patients in 24hrs regime group. Minor side effects were more commonly observed in 24hrs regime group. [n=38] of the students were underweight and 36 % [n=21] were obese. Twelve hours regime is equally effective as 24hours regime but with lesser side effects and so more cost effective. 12hours regime was observed to promote shorter hospital stay decreasing work load

Comparison of the effects of magnesium sulphate and dexmedetomidine on surgical vision quality in endoscopic sinus surgery: randomized clinical study / Comparação dos efeitos de sulfato de magnésio e da dexmedetomidina sobre a qualidade da visibilidade em cirurgia endoscópica sinusal: estudo clínico randomizado / Comparación de los efectos de sulfato de magnesio y dexmedetomidina sobre la calidad de la visibilidad en cirugía endoscópica sinusal: estudio clínico aleatorizado

Background and objectives: Even a small amount of bleeding during endoscopic sinus surgery can corrupt the endoscopic field and complicate the procedure. Various techniques, including induced hypotension, can minimize bleeding during endoscopic sinus surgery. The aim of this study was to compare the surgical vision quality, haemodynamic parameters, postoperative pain, and other effects of magnesium, a hypotensive agent, with that of dexmedetomidine, which was initially developed for short-term sedation in the intensive care unit but also is an alpha 2 agonist sedative. Method: 60 patients between the ages of 18 and 45 years were divided into either the magnesium group (Group M) or the dexmedetomidine group (Group D). In Group M, magnesium sulphate was given at a pre-induction loading dose of 50 mg kg−1 over 10 min and maintained at 15 mg kg−1 h−1; in Group D, dexmedetomidine was given at 1 mcg kg−1 10 min before induction and maintained at 0.6 mcg kg−1 h−1. Intraoperatively, the haemodynamic and respiratory parameters and 6-point intraoperative surgical field evaluation scale were recorded. During the postoperative period, an 11-point numerical pain scale, the Ramsay sedation scale, the nausea/vomiting scale, the adverse effects profile, and itching parameters were noted. Results: Group D showed a significant decrease in intraoperative surgical field evaluation scale scale score and heart rate. The average operation time was 50 min, and Group M had a higher number of prolonged surgeries. No significant difference was found in the other parameters. Conclusions: Due to its reduction of bleeding and heart rate in endoscopic sinus surgery and its positive impacts on the duration of surgery, we consider dexmedetomidine to be a good alternative to magnesium. .

Justificativa e objetivo: Uma quantidade, mesmo pequena, de sangramento durante a cirurgia endoscópica pode alterar o campo endoscópico e dificultar o procedimento. Várias técnicas, incluindo hipotensão induzida, podem minimizar o sangramento durante a cirurgia endoscópica. O objetivo deste estudo foi comparar a qualidade da visibilidade cirúrgica, os parâmetros hemodinâmicos, a dor no período pós-operatório e outros efeitos do sulfato de magnésio, um agente hipotensor, com os da dexmedetomidina, inicialmente desenvolvida para sedação em curto prazo em unidade de terapia intensiva, mas que também é um sedativo agonista alfa-2. Métodos: Foram alocados 60 pacientes entre 18 e 45 anos em dois grupos: Grupo M (magnésio) e Grupo D (dexmedetomidina). No Grupo M, sulfato de magnésio foi administrado pré-indução a uma dose de carga de 50 mg kg−1 por 10 minutos e mantida com 15 mg kg−1 h−1; no Grupo D, dexmedetomidina foi administrada a uma dose de 1 mcg kg−1 10 minutos antes da indução e mantida com 0,6 mcg kg−1 h−1. No período intraoperatório, foram registrados os parâmetros hemodinâmicos e respiratórios e a avaliação do campo cirúrgico com uma escala de seis pontos. Durante o período pós-operatório foram registrados os valores da escala numérica de 11 pontos para avaliar a dor, a escala de sedação de Ramsay, a escala de avaliação de náusea/vômito, o perfil dos efeitos adversos e pruridos. Resultados: O Grupo D apresentou redução significativa da frequência cardíaca e do escore na escala de avaliação do campo cirúrgico intraoperatório. A média do tempo cirúrgico foi de 50 minutos e o Grupo M apresentou um número maior de cirurgias prolongadas. ...

Introducción y objetivo: Una cantidad, aunque sea pequeña, de sangrado durante la cirugía endoscópica puede alterar el campo endoscópico y dificultar el procedimiento. Varias técnicas que incluyen hipotensión inducida pueden minimizar el sangrado durante la cirugía endoscópica. El objetivo de este estudio fue comparar la calidad de la visibilidad quirúrgica, los parámetros hemodinámicos, el dolor en el período postoperatorio y otros efectos del sulfato de magnesio, que es un agente hipotensor, con los de la dexmedetomidina, inicialmente desarrollada para la sedación a corto plazo en la unidad de cuidados intensivos, pero que también es un sedante agonista alfa-2. Método: 60 pacientes con edades entre 18 y 45 años se dividieron en 2 grupos: grupo M (magnesio) y grupo D (dexmedetomidina). En el grupo M, el sulfato de magnesio fue administrado antes de la inducción en dosis de carga de 50 mg kg−1 por 10 min y se mantuvo con 15 mg kg−1 h−1; en el grupo D, la dexmedetomidina fue administrada con una dosis de 1 µg kg−1 durante 10 min antes de la inducción y se mantuvo con 0,6 µg kg−1 h−1. En el período intraoperatorio se registraron los parámetros hemodinámicos y respiratorios y la evaluación del campo quirúrgico con una escala de 6 puntos. Durante el postoperatorio también se registraron la escala numérica de 11 puntos para evaluar el dolor, la escala de sedación de Ramsay, la escala de evaluación de náuseas/vómito, el perfil de los efectos adversos y los pruritos. Resultados: El grupo D tuvo una reducción significativa de la frecuencia cardíaca y de la puntuación en la escala de evaluación del campo quirúrgico intraoperatorio. La media del tiempo quirúrgico fue de 50 min, y el grupo M tuvo un número mayor de ...

Have magnesium sulfate, acetic acid, meprobamate and fluoxetine an anti-arthrogenic activity?

Atherosclerosis is a progressive inflammatory disorder of the arterial wall that is characterized by focal lipid rich deposits of atheroma with possible correlation with sedative hypnotics in decreasing atherogenesis. This study was performed in Al-Kadhimiya teaching hospital from February 2009 to June 2009 on sixty healthy males who were allocated to six groups. Each group was given one of the following agents: Magnesium sulfate [MgSo4], acetic acid, Meprobamate, Fluoxetine in addition to Simvastatin and water. Clinical manifestations like [arterial blood pressure, radial pulsation], lipid profiles [serum cholesterol, triglycerides, HDL, LDL and VLDL] total free radicals and platelets function tests are the parameters used in this study. All the tested agents reduce both the serum cholesterol concentration and total blood free radicals significantly; also they decrease both platelet count and adhesion test significantly. Both MgSo4 and Meprobamate lowered blood pressure and serum triglyceride concentration significantly, at the same time HDL concentration significantly changed by Fluoxetine when these parameters measured before and after treatment for 15 days. MgSo4, acetic acid, Meprobamate and Fluoxetine were found to have anti-arthrogenic activity and the possibility to be used clinically in atherosclerosis

Comparación de la eficacia y seguridad de dos combinaciones nebulizadas; sulfato de magnesio mas salbutamol versus salbutamol mas solucion salina normal, en el tratamiento del sindrome bronquial obstructivo en pediatría / Comparison of efficacy and safety of two nebulised combinations: magnesium sulfate more salbutamol versus salbutamol more normal saline solution in the treatment of obstructive bronchial syndrome In a pediatric populación

Los síndromes bronquiales obstructivos constituyen una patología muy frecuente y recurrente en la población pediátrica. El tratamiento convencional, incluye el uso de beta dos agonistas nebulizados de corta acción y esteroides sistémicos. Sin embargo existe una proporción de pacientes que no responden a ésta terapia por lo que son justificadas la utilización de otras medidas como ser la combinación nebulizada de sulfato de magnesio más salbutamol el cuál será el objetivo a investigar desde el punto de vista de eficacia y seguridad en comparación a la combinación nebulizada de salbutamol más solución salina normal, con el propósito de sugerir - sí resultase útil - una nueva alternativa de tratamient o. Se estudiaron 100 pacientes, 44 recibieron la combinación de magnesio con salbutamol y el resto salbutamol con solución salina; el 93% del grupo inicial presentó resolución total de su cuadro en las primeras 12 horas en comparación al 63% del grupo con la segunda combinación (p=0.003). Ambas combinaciones fueron seguras...(AU)

Usos do sulfato de magnésio em obstetrícia e em anestesia: [revisão] / Applications of Magnesium Sulfate in Obstetrics and Anesthesia: [review] / Usos del sulfato de magnesio en obstetricia y en anestesia: [revisión]

Justificativa e objetivos: O magnésio é um íon predominantemente intracelular. Seu efeito bloqueador do receptor NMDA lhe confere características analgésicas e sedativas. O objetivo desse artigo foi revisar a fisiologia, a farmacologia e a diminuição da concentração plasmática do magnésio, assim como algumas das suas aplicações em obstetrícia e em anestesia. Conteúdo: O magnésio é um cátion intracelular que possui múltiplas funções: é cofator de enzimas do metabolismo glicídico e de enzimas da degradação dos ácidos nucleicos, proteínas e ácidos graxos; regula a passagem de íons transmembrana e intervém na atividade de várias enzimas. O paciente em estado crítico apresenta tendência à hipomagnesemia e o tratamento consiste em corrigir a causa quando possível acompanhada da reposição do magnésio. Já foi demonstrada a redução da concentração alveolar mínima (CAM) dos agentes inalatórios em animais e do uso de opioides em humanos sob anestesia. Conclusões: O sulfato de magnésio vem sendo utilizado em obstetrícia com boa efetividade para inibição do trabalho de parto prematuro e para o tratamento das crises convulsivas associadas ao quadro de eclâmpsia. É um fármaco com potencial analgésico e sedativo que pode ser utilizado como coadjuvante durante a anestesia geral atenuando a resposta pressórica à intubação traqueal e diminuindo a necessidade de anestésicos.

Background and objectives: Magnesium is predominantly an intracellular ion. Its blocking effects on NMDA receptors are responsible for the analgesic and sedative characteristics of this ion. The objective of this study was to review the physiology, pharmacology, and decreased plasma levels of magnesium, as well as its applications in obstetrics and anesthesia. Contents: Magnesium is an intracellular cation with multiple functions: it is a cofactor for enzymes of the glucose metabolism and those that participate in the degradation of nucleic acids, proteins, and fatty acids; it regulates the movements of transmembrane ions; and it intervenes in the activity of several enzymes. Critical patients have a tendency to develop hypomagnesemia, and the treatment consists in correcting the cause, whenever possible, and replacement of magnesium. A reduction in the minimum alveolar concentration (MAC) of inhalational agents in animals and the use of opioids in humans under anesthesia has been demonstrated. Conclusions: Magnesium sulfate has been used in obstetrics with good results, inhibiting premature labor and in the treatment of eclampsia-associated seizures. It is potentially analgesic and sedative, and could be used as adjuvant during general anesthesia, attenuating the blood pressure response to tracheal intubation and decreasing the need of anesthetics.

Justificativa y objetivos: El magnesio es un ión predominantemente intracelular. Su efecto bloqueador del receptor NMDA le confiere características analgésicas y sedativas. El objetivo de este artículo, fue revisar la fisiología, la farmacología y la disminución de la concentración plasmática del magnesio, como también de algunas de sus aplicaciones en obstetricia y en anestesia. Contenido: El magnesio es un catión intracelular que posee múltiples funciones: es cofactor de enzimas del metabolismo glicídico y de enzimas de la degradación de los ácidos nucleicos, proteínas y ácidos grasos; regula el paso de los iones transmembrana e interviene en la actividad de varias enzimas. El paciente en estado crítico, presenta una tendencia a la hipomagnesemia, y el tratamiento consiste en corregir la causa cuando es posible, acompañada de la reposición del magnesio. Ya ha quedado demostrada la reducción de la concentración alveolar mínima (CAM), de los agentes inhalatorios en animales y el uso de opioides en humanos bajo anestesia. Conclusiones: El sulfato de magnesio, ha venido siendo utilizado en obstetricia con una buena efectividad para la inhibición del parto prematuro y para el tratamiento de las crisis convulsivas asociadas al cuadro de eclampsia. Es un fármaco con potencial analgésico y sedativo que puede ser utilizado como coadyuvante durante la anestesia general, atenuando la respuesta presórica a la intubación traqueal y disminuyendo la necesidad del uso de anestésicos.

Efeito do sulfato de magnésio sobre o índice de pulsatilidade das artérias uterinas, umbilical e cerebral média fetal de acordo com a persistência da incisura protodiastólica da artéria uterina na pré-eclâmpsia grave / Effect of magnesium sulfate on pulsatility index of uterine, umbilical and fetal middle cerebral arteries according to the persistence of bilateral diastolic notch of uterine arteries in patients with severe preeclampsia

OBJETIVO: avaliar o efeito do sulfato de magnésio sobre o índice de pulsatilidade (IP) das artérias uterinas, umbilicais e cerebral média fetal, de acordo com a persistência ou não da incisura protodiastólica bilateral das artérias uterinas na pré-eclâmpsia grave. MÉTODOS: foi desenvolvido um estudo do tipo coorte, incluindo 40 gestantes com pré-eclâmpsia grave, das quais 23 apresentavam incisura protodiastólica bilateral e 17, incisura ausente/unilateral. As pacientes foram submetidas a doplervelocimetria antes e depois de 20 minutos da administração intravenosa de 6 g do sulfato de magnésio. O exame foi realizado com a paciente em posição semi-Fowler, obtendo-se os sonogramas durante a inatividade fetal, em períodos de apneia e ausência de contrações uterinas. Todos os exames foram realizados por dois pesquisadores, considerando a média como resultado final. A comparação dos IP antes e depois do sulfato de magnésio em cada grupo foi realizada pelo teste de Wilcoxon. A diferença das duas medidas (antes e depois do sulfato de magnésio) foi comparada entre os grupos (incisura bilateral e incisura ausente/unilateral) utilizando-se o teste de Mann-Whitney. RESULTADOS: houve um aumento significativo da frequência cardíaca materna e uma diminuição da pressão arterial materna e da mediana dos IP das duas artérias uterinas e da artéria cerebral média fetal depois da utilização do sulfato de magnésio em ambos os grupos. Houve redução significativa do IP da artéria uterina esquerda e da artéria umbilical apenas no grupo com incisura protodiastólica unilateral/ausente. No entanto, não foram encontradas diferenças significativas em relação ao IP da artéria uterina direita e relação umbilical/cerebral antes e depois do sulfato de magnésio em cada grupo. Não se encontrou diferença entre os grupos, antes e depois do sulfato de magnésio, para nenhum dos desfechos estudados. CONCLUSÕES: após a administração intravenosa de 6 g do sulfato de magnésio nas...

PURPOSE: to evaluate the effect of magnesium sulphate on the pulsatility index (PI) of the uterine, umbilical and fetal middle cerebral arteries, according to the persistency or not of the bilateral protodiastolic notch of the uterine arteries in severe pre-eclampsia. METHODS: a cohort study including 40 pregnant women with severe pre-eclampsia, 23 of them presenting bilateral protodiastolic notch, and 17, unilateral/absent notch. The patients were submitted to Doppler velocimetry before and 20 minutes after the intravenous administration of 6 g of magnesium sulphate. The examination was carried out with the patient in semi-Fowler position, the sonograms being obtained during fetal inactivity, in apnea and absent uterine contraction periods. All the exams were performed by two researchers, the average being considered as the final result. Wilcoxon's test was used to compare the PI, before and after magnesium sulphate in both groups. The difference between the two measurements (before and after magnesium sulphate) was compared between the groups (bilateral incision and unilateral/absent incision) using the Mann-Whitney test. RESULTS: there was a significant increase in the maternal heart rate (MHR) and decrease in the maternal blood pressure, and in the PI medians of the two uterine arteries and in the fetal middle cerebral artery, after magnesium sulphate in both groups. There was a significant decrease in the PI of the left uterine artery and in the umbilical artery, only in the protodiastolic unilateral/absent notch group. Nevertheless, it was not found any significant difference regarding the PI of the right uterine artery, or the cerebral/umbilical relationship, before and after magnesium sulphate in each group. No difference between the groups was found, before and after magnesium sulphate, for any of the studied outcomes. CONCLUSIONS: after the intravenous administration of 6 g of magnesium sulphate to patients with severe pre-eclampsia...

"Después de la tormenta sobreviene la calma": hipertensión inducida por el embarazo y desprendimiento seroso de la retina: angiografía fluoresceínica evolutiva / Calm follows storm: pregnant induced hypertension and serous retinal detachment: sequential fluorescein angiography

El desprendimiento seroso de la retina es una rara complicación de la hipertensión inducida por el embarazo. Se ha reportado en 1% a 2% de pacientes con eclampsia severa siendo usualmente bilateral. En esta condición, la isquemia coroidea inducida por el vasoespasmo suele ser severa y es la responsable de la ruptura de la barrera hematorretiniana externa y del desprendimiento. La mayoría de los pacientes obtienen recuperación espontánea en el curso de pocas semanas sin secuelas visuales, quedando como evidencia cambios pigmentarios residuales en el epitelio pigmentario de la retina. En una secuencia de angiografías fluoresceínicas del fondo ocular de una embarazada de 31 años mostramos la historia natural de la complicación

Serous retinal detachment is an unusual complication of the hypertensive disorder in pregnancy. It has been reported in 1% to 2% of patients with severe preeclampsia and 10% with eclampsia and is usually bilateral. In this condition choroidal ischemia induced by vasospasm may be severe compromising the retinal-pigmentary epithelium barrier and resulting in serous retinal detachment. Most patients with retinal detachment in pregnancy-induced hypertension have had full spontaneous resolution within a few weeks, and they did not have any visual sequelae but residual pigmentary changes of the retinal pigment epithelium. The natural history of the condition is shown in sequential fluoresce in angiography studies in a 31 year-old pregnant patient

Effects of magnesium sulphate in delibrated hypotension for mastoidectomy surgery

Deliberated hypotension and administration of vasoconstrictive drugs such as epinephrine during ear microsurgery are of the most important aids for reducing blood loss and improving the surgical field. One of the important challenges in selecting the appropriate method of deliberated hypotension is to easily reach to desired blood pressure and to have the least interaction to anesthetic drugs and the function of vital organs. This study aimed to assess the efficacy of magnesium sulphate for deliberated hypotension during ear microsurgery. In this clinical trial, 55 patients candidate for mastoidectomy surgery, and aged 15-65 yrs, were randomly assigned to receive placebo [n=27] or magnesium sulphate [n=28] infuse 60 mg/Kg over 15 minute followed by a maintenance dose of 10 mg/Kg/h until 30 minutes prior to the end of surgery. Intra-operative bleeding, the surgery duration, surgeon satisfaction, serum magnesium level, recovery time, anesthetic drug requirements [atracurium-halothane], and vasodilator [TNG] were measured in both groups and then compared with independent t and Mann-Whitney statistical tests. Patients receiving magnesium sulphate had less blood loss than controls [59.46 +/- 27.19 vs. 97.57 +/- 31.41 ml, respectively, p<0.01]]. Serum magnesium levels were in the therapeutic range [3.1 +/- 0.78 meq/L]. Patients had no significant arrhythmia, received lower doses of T.N.G [101.71 +/- 56.69 vs. 1107 +/- 450.45 /g]], and muscle relaxant [45.89 +/- 14.08 vs. [60.17 +/- 9.76 mg, respectively,p<0.01] but not significant difference in Halothane [[3.1 +/- 0.64 MAC/hr] vs. [3.45 +/- 0.6 MAC/hr]]. Also surgeon satisfaction was better in magnesium group [p<0.001]. There were not statistically difference in surgical time [[155.71 +/- 27.27 min] vs. [157.50 +/- 33.62 min]] and recovery time [[44.64 +/- 7.92 min] vs. [45.71 +/- 8.99 min]] between two groups. Administration of intravenous magnesium sulphate as a hypotensive drug in mastoidectomy surgery may be effective in decreasing intraoperative bleeding, using atracurium and TNG drugs,however in spite of improvement of the surgeon satisfaction, it had no effect on reducing the duration of surgery and recovery time. Overall, its administration is recommended for deliberate hypotension is a feasible method in mastoidectomy surgery

Comparative study between Magnesium and dexmedetomidine as adjuvant to lidocaine for intravenous regional anesthesia

We conducted this study to evaluate the effects of magnesium and dexmedetomidine when added to lidocaine for intravenous regional anesthesia [IVRA]. Forty-five patients undergoing elective hand surgery during IVRA were randomly assigned to three groups. IVRA was achieved with 10ml of saline plus 3mg/kg lidocaine 0.5% diluted with saline to a total of 40ml in group L, 10ml of 10% magnesium sulfate plus 3mg/kg lidocaine 0.5% diluted with saline to a total of 40m1 in group M and 0.5micro g/kg dexmedetornidine plus 3mg/kg lidocaine 0.5% diluted with saline to a total close of 40ml in group D. Injection pain, sensory and motor block onset and recovery time, tourniquet pain, and anesthesia quality were noted, Patients were instructed to receive 75mg of IM diclofenac when the visual analog scale [VAS] score was >4, and analgesic requirements were recorded. Sensory and motor block onset times were shorter and recovery times were prolonged in group M and D. VAS scores of tourniquet pain were lower in group M and D at 15, 20, 30, 40 and 50mm [p<0.001]. Anesthesia quality, as determined by the anesthesiologist and surgeon, was better in group M and D [p<0.05]. Time to the first postoperative analgesic request was 95 +/- 29, l55 +/- 38, 170 +/- 20min in groups L, M, D respectively. There was a statistically difference in VAS scores for tourniquet pain at 15. 20, 30, 40 and 50min after tourniquet inflation [p<0.001]: VAS scores were lower in group M and D. Postoperative VAS scores were significantly higher for the first postoperative 6 hours in group L compared with group M [p<0.05]. In group D, postoperative VAS scores were significantly lower for the first postoperative 12 hours compared with group M and L. Diclofenac consumption was significantly less in group M [50 +/- 35mg] and group D [40 +/- 10mg] compared with group L [130 +/- 55mg] and in group D compared with group M [p<0.05]. No adverse effects were seen through the 24 hours postoperative period in the three groups. We conclude that magnesium and dexmedetomidine as an adjuncts, to lidocaine improves the quality of anesthesia and analgesia in IVRA, more in dexmedetomidine group

Effects of Magnesium Sulfate on Supraceliac Aortic Unclamping in Experimental Dogs

Intravascular administration of magnesium (Mg) causes vasodilation and increases renal blood flow. The aim of this study was to investigate the renal effect of Mg following unclamping of the supraceliac aorta. Mongrels were divided into two groups, control (group C, n=7) and Mg group (group Mg, n=7). In group Mg, 30 mg/kg MgSO4 was injected as a bolus immediately prior to unclamping the supraceliac aorta and thereafter as an infusion (10 mg/kg/hr). The group C received an equivalent volume of saline solution. Systemic hemodynamics, renal artery blood flow, renal cortical blood flow (RCBF), renal vascular resistance, and renal function were compared. Following the aortic unclamping, cardiac output and RCBF were less attenuated, and the systemic and renal vascular resistance was elevated to a lesser degree in the group Mg compared to the group C. There was no significant difference in the plasma renin activity, serum creatinine and Cystatin-C between the two groups. The present study shows that Mg infusion improves systemic hemodynamics and RCBF after aortic unclamping. However, we did not observe any improvement in renal function when Mg was administered after supraceliac aortic unclamping.

MgSO4 supplementation: effect on hemodynamic to tracheal intubation, intra and postoperative analgesia in pre-eclamptic patients undergoing cesarean section

Magnesium is known to have an antinociceptive value, being a natural physiologic calcium antagonist, [N-Methy1-D-Aspartate] receptor antagonist, and also inhibits catecholamine release from the adrenergic nerve terminals. This study was performed to investigate the effect of m[g]so[4] on the stress response to laryngoscxopy, endotracheal intubation and surgery, as well as the postoperative analgesic repuriements and possible side effects to the fetus of the mother in forty parturients with moderate to sever pre-eclampsia undergoing cesarean section [c.s] under general anaesthesia. Parturients were divided into two group [each 20 patients]. The mg group: received a bolus of m[g]so[4], 50mg/kg before intubation followed by infusion at a rate of 8 mg/kg/hour and for 6 hour postoperatively. The control-group: received xylocaine bolus 1.5 mg/kg pre-intubation followed by infusion of equal volume of m[g] free acetated ringer solution for the same period. General anaesthesia induced by sodium thiopentone, m[g] or xylocaine bolus, succinly choline, orotracheal intubation, mechanical ventilation by isoflurane 0.5% and N2O: O2 50%. Standard monitoring was used. Fentanyl [1-2 MICRO g/kg] was given after delivery of the baby as needed. Total intraoperative fentanyl was recorded as well as the total postoperative meperidine requirements. Maternal blood samples were collected, preoperative, after intubation, after delivery of the baby, early postoperative, 2 hour, 6 hours postoperatively for serum m[g] level. Cord blood was sampled for serum m[g] and fetal acid-base-status. Neonates were scored on the apgar system at 1 and 5 minutes. Postoperative pain and isomnia were assessed using visual analogue scales for 6 hours postoperatively as well as any possible maternal side effects [e.g, bleeding, vomiting, shivering]. Our results showed that the use of m[g]ao[4] was associated with better response to the stress of laryngoscopy and intubation as showed by the less significant changes in the means of heart rate and mean artrial pressure, and significant reduction of the total intra-and postoperative analgesic requirements, without any significant side effects on the number or the newborn. M[g]so[4] is a useful adjuvant to perioperative anesthetic management in pre-eclamptic parturients undergoing cesarean section under general anaesthesia

Aerobic growth of motile and non-motile bacteria an the surface of solid culture medium in the presence of the heavy metal and ionic salts at two temperatures

Threshold concentrations of heavy metal and ionic salts defining the range of Concentrations, that do not suppress growth, were determined in tryptic soya agar medium. It has been found that the salts of NH4, Mg, Cd and Hg at low concentrations disrupt the symbiotic relationship between the solid surface culture medium and the microorganisms, but do not suppress the growth of the bacteria. These compounds have been included under two different groups as infection inhibitors [Cd and Hg] and as an infection stimulators [NH4, Mg and K]

Role of N-methyl-D-aspartate receptor antagonists as adjuvants to general anesthesia in postoperative analgesia

In the present study, postoperative pain was assessed in 48 patients undergoing elective abdominal surgery in the National Cancer Institute, Cairo University, with 3 different adjuvant medications; namely, saline [control group], magnesium sulfate [MgSO4] [group II] and low dose ketamine [group III] as physiologic NMDA receptor antagonists. After surgery, it was found that the time from the end of surgery to the first request for analgesia was longer in both [MgSO4] and ketamine group. Postoperatively, patients were treated with patient controlled analgesia [PCA] in exactly the same way. There was a statistically significant difference with reduced dose requirement of morphine in both MgSO4 and ketamine groups, compared with the control group after the operation. Mean visual analog scale [VAS] and verbal rating scale [VRS] were higher in patients of the control during the first 6 hours after surgery. Between 6 and 24 hours after surgery VAS and VRS were not significantly different. The results indicate that NMDA receptor antagonists could be of clinical interest as adjuvants to general anesthesia, as they were associated with smaller analgesic requirement than the control group in the postoperative period without adverse effects

Mecanismos involucrados en el efecto antiarritmico y proarritmico del magnesio / Mechanisms involved in the antiarrhythmic and proarrhythmic effects of magnesium

El objetivo fue analizar en perros, los efectos del MgCl2, y del MgSO4 sobre los mecanismos electrofisiológicos que pudieran vincularse con las acciones antiarrítmicas y proarrítmicas de estas soluciones. Se estudiaron previamente los parámetros farmacocinéticos del MgCl2 y del MgSO4; ambos mostraron que el Mg plasmático disminuye exponencialmente (constante beta de O,118 ñ O,013 h-l), t 1/2 de eliminación de 6,02 ñ O,68 h y una Vda de O,259 ñ O,02lxkg-l. Posteriormente se estudiaron dos grupos de animales - Grupo I: dieta normal. Grupo II A: dieta sin Mg + clortalidona + K y Grupo II B: dieta sin Mg + clortalidona + KCI + MgSO4. Se midieron los electrolitos y las variables electrofisiológicas por medio de estimulación ventricular programada. El grupo I mostró que la administración de MgSO4 endovenoso disminuye el Na, el K y el umbral de fibrilación ventricular (UFV) y prolonga el período refractaria efectivo ventricular (PREV). El MgCl2 no modifica el UFV, pero prolonga el PREV, el A-H, el QTc y el PQ. El MgSO4 aumenta la excreción de K urinario en forma significativamente mayor que el MgCl2. La administración de NaCl no alteró las variables electrofisiológicas pero el NaSO4 disminuyó el K plasmático, sin modificar el UFV. El Grupo II A presentó descenso del K y Mg plasmático, linfocitario y miocárdico, disminución del PREV y del UFV y aumento del QTc. A este grupo se le administro en forma aguda: 1) MgSO4 que provocó mayor descenso del UFV y del K plasmático y aumento del PREV y 2) KCI que aumento el K piasmático y el UFV. El grupo II B no modificó los electrolitos ni las variables electrofisiológicas. Se concluye que los efectos antiarrítmicos observados en clínica por la administración de sales de Mg se deberían probablemente a la prolongación del PREV. Sin embargo, la depleción de K inducida por el MgSO4 puede provocar un descenso del UFV, efecto proarrítmico que se podría evitar utilizando MgCl2.

role of magnesium and calcium ions in atrial natriuretic peptide secretion

For the purpose of examining the role of calcium and magnesium ions in the secretory process of atrial natriuretic peptide [ANP], we studied the effects of hypercalcemia, digitalis "Lanoxine", calcium ion channel blocker "verapamil", hypermagnesemia, potassium ion channel blocker "Glibenclamid", and potassium ion channel opener "cromakalim" on plasma concentration of immunoreactive ANP [ir ANP]. Pentobarbital-anesthetized dogs [n-36] were divided into-6-equal groups [6 each] and treated separately with calcium chloride infusion [0.136 mmol/Kg/min-10 min]. Lanoxine injection [30 micro g/Kg], verapamil injection [300 micro g/Kg], magnesium sulfate infusion [0.168 mmol/Kg/min-10 min] after an initial bolus dose of 1.5 mmol/Kg, glibenclamid injection [0.3 mg/Kg], and cromakalim injection [10 micro g/Kg]. Plasma ir ANP concentrations, mean arterial pressure [MAP], heart rate [HR] and serum calcium and magnesium concentrations were measured. With calcium chloride and magnesium sulfate infusions, serum calcium and magnesium levels and plasma ir ANP concentrations were significantly increased. Also, lanoxine and K[+] -channel blocker "glibenclamid" caused a significant increase in plasma ir ANP concentration while verapamil and the K[+]-channel opener "cromakalim" resulted in a significant decrease. Neither calcium chloride nor lanoxine produced a significant effect on heart rate, but both significantly increased MAP. In contrast, magnesium sulfate and verapamil produced a significant decrease in MAP and HR while glibenclamid and cromakalim were associated with insignificant changes in both HR and MAP. These results suggest that calcium ions may play a key role in the secretory process of ANP and indicate that magnesium ions may also influence ANP secretion by acting via modulation of K[+] -channels